Adiponectin activates the AMP-activated protein kinase (AMPK) and mitogen-activated protein kinase (MAPK) pathways in myeloma cells, and reduces the rate of tumour cell proliferation while promoting apoptosis[123]. Here, ADIPOQ is linked to plasma cell myeloma.